Disclosure 0001193125-26-368244-2

SEC FORM 4

$1,046,420.57

Rapport Therapeutics, Inc. (RAPP)

Sale of 20,799 shares at $50.3111 per share.

Reporting Person Yeleswaram Krishnaswamy · Officer Title Chief Development Officer · Transaction Code S

Traded Aug 25, 2026 · Disclosed Aug 26, 2026

Source: SEC Form 4 · 0001193125-26-368244 · filed 2026-08-26 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Rapport Therapeutics, Inc. (RAPP)." Disclosed 2026-08-26. https://desqlong.com/cards/0001193125-26-368244-2 (retrieved 2026-09-26).